Exelixis Inc (EXEL)
35.62
+0.79
(+2.27%)
USD |
NASDAQ |
Nov 22, 12:36
Exelixis Total Liabilities (Quarterly): 684.86M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 684.86M |
| June 30, 2024 | 653.39M |
| March 31, 2024 | 675.74M |
| December 31, 2023 | 678.44M |
| September 30, 2023 | 629.29M |
| June 30, 2023 | 614.53M |
| March 31, 2023 | 588.22M |
| December 31, 2022 | 583.06M |
| September 30, 2022 | 469.97M |
| June 30, 2022 | 490.14M |
| March 31, 2022 | 360.27M |
| December 31, 2021 | 405.62M |
| September 30, 2021 | 335.29M |
| June 30, 2021 | 324.19M |
| March 31, 2021 | 279.36M |
| December 31, 2020 | 258.22M |
| September 30, 2020 | 259.01M |
| June 30, 2020 | 213.22M |
| March 31, 2020 | 207.95M |
| December 31, 2019 | 199.70M |
| September 30, 2019 | 181.15M |
| June 30, 2019 | 154.47M |
| March 31, 2019 | 156.77M |
| December 31, 2018 | 134.83M |
| September 30, 2018 | 108.40M |
| Date | Value |
|---|---|
| June 30, 2018 | 136.19M |
| March 31, 2018 | 105.15M |
| December 31, 2017 | 370.33M |
| September 30, 2017 | 371.06M |
| June 30, 2017 | 368.02M |
| March 31, 2017 | 467.23M |
| December 31, 2016 | 506.42M |
| September 30, 2016 | 516.47M |
| June 30, 2016 | 663.27M |
| March 31, 2016 | 648.49M |
| December 31, 2015 | 473.15M |
| September 30, 2015 | 437.47M |
| June 30, 2015 | 436.97M |
| March 31, 2015 | 429.69M |
| December 31, 2014 | 438.10M |
| September 30, 2014 | 442.17M |
| June 30, 2014 | 437.39M |
| March 31, 2014 | 426.08M |
| December 31, 2013 | 437.05M |
| September 30, 2013 | 423.20M |
| June 30, 2013 | 415.75M |
| March 31, 2013 | 404.68M |
| December 31, 2012 | 424.66M |
| September 30, 2012 | 421.77M |
| June 30, 2012 | 275.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
199.70M
Minimum
Dec 2019
684.86M
Maximum
Sep 2024
445.52M
Average
437.80M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 72.97B |
| ADMA Biologics Inc | 158.73M |
| Vericel Corp | 132.93M |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Inovio Pharmaceuticals Inc | 33.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.960B |
| Shareholders Equity (Quarterly) | 2.275B |
| Current Ratio | 3.930 |